3,131 Shares in Tenet Healthcare Corporation $THC Bought by Empirical Finance LLC

Empirical Finance LLC bought a new stake in Tenet Healthcare Corporation (NYSE:THC) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 3,131 shares of the company’s stock, valued at approximately $586,000.

Several other large investors also recently made changes to their positions in the stock. Jackson Creek Investment Advisors LLC lifted its position in shares of Tenet Healthcare by 235.6% during the 4th quarter. Jackson Creek Investment Advisors LLC now owns 9,032 shares of the company’s stock worth $1,795,000 after purchasing an additional 6,341 shares during the last quarter. Hsbc Holdings PLC lifted its position in Tenet Healthcare by 3,478.7% in the fourth quarter. Hsbc Holdings PLC now owns 266,400 shares of the company’s stock worth $53,269,000 after purchasing an additional 258,956 shares during the period. Brandywine Global Investment Management LLC boosted its position in shares of Tenet Healthcare by 20.5% during the 4th quarter. Brandywine Global Investment Management LLC now owns 126,248 shares of the company’s stock valued at $25,088,000 after acquiring an additional 21,435 shares in the last quarter. Louisiana State Employees Retirement System acquired a new stake in Tenet Healthcare during the first quarter valued at approximately $4,812,000. Finally, Cerity Partners LLC boosted its stake in Tenet Healthcare by 8.4% in the 4th quarter. Cerity Partners LLC now owns 156,141 shares of the company’s stock valued at $31,028,000 after buying an additional 12,060 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

Insider Buying and Selling at Tenet Healthcare

In related news, Director Tammy Romo sold 4,922 shares of the stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $264.15, for a total value of $1,300,146.30. Following the sale, the director owned 30,784 shares in the company, valued at approximately $8,131,593.60. This represents a 13.78% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Lisa Foo sold 24,000 shares of the stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $266.32, for a total transaction of $6,391,680.00. Following the completion of the transaction, the executive vice president directly owned 8,053 shares in the company, valued at $2,144,674.96. The trade was a 74.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 109,189 shares of company stock worth $29,264,109 in the last three months. 0.97% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Mizuho set a $290.00 price target on shares of Tenet Healthcare in a report on Monday, August 10th. Morgan Stanley upped their price target on Tenet Healthcare from $254.00 to $274.00 and gave the company an “overweight” rating in a research note on Monday, July 27th. TD Cowen lifted their target price on shares of Tenet Healthcare from $233.00 to $263.00 and gave the stock a “buy” rating in a report on Monday, July 27th. Robert W. Baird boosted their price target on shares of Tenet Healthcare from $210.00 to $280.00 and gave the company a “neutral” rating in a report on Tuesday, July 28th. Finally, Stephens reiterated an “overweight” rating and issued a $285.00 price objective on shares of Tenet Healthcare in a research report on Monday, July 27th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, Tenet Healthcare presently has a consensus rating of “Buy” and a consensus price target of $275.53.

Tenet Healthcare Stock Down 2.0%

THC stock opened at $263.75 on Friday. The company has a market cap of $21.24 billion, a price-to-earnings ratio of 10.17, a P/E/G ratio of 1.03 and a beta of 1.23. Tenet Healthcare Corporation has a twelve month low of $157.58 and a twelve month high of $283.05. The business has a 50 day moving average price of $243.84 and a two-hundred day moving average price of $212.04. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. The firm had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the company posted $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Analysts anticipate that Tenet Healthcare Corporation will post 21.04 EPS for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company that owns and operates acute care hospitals and other healthcare facilities in the United States. Its hospitals provide services including emergency care, surgery, cardiovascular care, orthopedics, oncology, women’s health and other inpatient and outpatient treatments.

Through its ambulatory business, United Surgical Partners International, Tenet operates and manages ambulatory surgery centers and other outpatient facilities.